Table 4 Agreement between primary care and patient questionnaire data (n = 356)
Characteristic | N | Mean difference | 95% Limits of agreement | Â |
Age, years | 352 | 0.32 | − 2.17, 2.81 |  |
HbA1c, mmol/mol | 40 | − 0.66 | − 11.33, 10.00 |  |
Characteristic | Categories | N(%) agree | N(%) disagree | % Agreement |
Sex | Male | 212 (99.5) | 1 (0.5) | Â |
Female | 142 (100.0) | 0 (0.0) | 99.7 | |
Ethnicity | White | 256 (93.8) | 17 (6.2) | Â |
South Asian | 13 (81.3) | 3 (18.7) | Â | |
Black | 5 (83.3) | 1 (16.7) | Â | |
Other | 1 (50.0) | 1 (50.0) | 92.6 | |
HbA1c measured in the last 12 months | Yes | 323 (97.9) | 7 (2.1) |  |
No | 9 (81.8) | 2 (18.2) | 94.7 | |
HbA1c result, mmol/mol | ≤ 53 (≤ 7%) | 108 (93.1) | 8 (6.9) |  |
54–69 (7.1–8.5%) | 43 (61.4) | 27 (38.6) |  | |
70–86 (8.6–10.0%) | 5 (33.3) | 10 (66.7) |  | |
≥ 87 (≥ 10.1%) | 2 (28.6) | 5 (71.4) | 76.0 | |
Diabetes management | Diet and lifestyle | 71 (88.9) | 9 (11.3) | Â |
DPP-IV | 5 (71.4) | 2 (28.6) | Â | |
GLP-I | 1 (100.0) | 0 (0.0) | Â | |
Insulin | 15 (75.0) | 5 (25.0) | Â | |
Metformin | 118 (96.7) | 4 (3.3) | Â | |
SGLT-2 | 1 (100.0) | 0 (0.0) | Â | |
Sulphonylurea | 8 (100.0) | 0 (0.0) | Â | |
Multiple diabetes medications | 3 (2.9) | 101 (97.1) | Â | |
Other | 0 (0.0) | 0 (0.0) | 55.9 | |
SSME referral | No | 101 (76.5) | 31 (23.5) | Â |
Yes | 111 (54.2) | 94 (45.9) | 59.6 | |
Date of SSME referral | ≤ 1 year | 26 (76.5) | 8 (23.5) |  |
> 1 year | 67 (91.8) | 6 (8.2) | 86.9 | |
SSME attendance | No | 169 (96.6) | 6 (3.4) | Â |
Yes | 78 (46.4) | 90 (54.6) | 72.0 | |
Date of SSME attendance | ≤ 1 year | 13 (100.0) | 0 (0.0) |  |
> 1 year | 37 (82.2) | 8 (17.8) | 86.2 |